Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. SURGICAL'S RAY SPINAL FUSION CAGE APPROVABLE WITH CONDITIONS FOR POSTERIOR USE, PANEL SAYS; POSTMARKET STUDY, LABELING CHANGES SUGGESTED

This article was originally published in The Gray Sheet

Executive Summary

U.S. Surgical's Ray threaded spinal fusion cage is conditionally approvable for treatment of symptomatic degenerative disk disease of the lumbar spine via a posterior surgical approach, FDA's Orthopedic and Rehabilitation Devices Advisory Panel concluded in a 7-1 vote at a May 23 meeting in Gaithersburg, Md.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT006058

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel